CD24: A Novel Target for Cancer Immunotherapy E Panagiotou, NK Syrigos, A Charpidou, E Kotteas, IA Vathiotis Journal of Personalized Medicine 12 (8), 1235, 2022 | 70 | 2022 |
Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials E Panagiotou, G Gomatou, IP Trontzas, N Syrigos, E Kotteas Clinical and Translational Oncology 24 (2), 161-192, 2022 | 64 | 2022 |
BRAF/MEK inhibition in NSCLC: Mechanisms of resistance and how to overcome it I Tsamis, G Gomatou, SP Chachali, IP Trontzas, V Patriarcheas, ... Clinical and Translational Oncology 25 (1), 10-20, 2023 | 20 | 2023 |
Leveraging sequences missing from the human genome to detect cancer OY Barnea, I Georgakopoulos-Soares, N Ahituv, J Chapman, M Hemberg, ... Cancer Research 83 (7_Supplement), 991-991, 2023 | 11* | 2023 |
Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes D Mavroeidi, A Georganta, E Panagiotou, K Syrigos, VL Souliotis International Journal of Molecular Sciences 25 (5), 2767, 2024 | 6 | 2024 |
Emerging therapies in thymic epithelial tumors A Dapergola, G Gomatou, I Trontzas, E Panagiotou, E Dimakakos, ... Oncology Letters 25 (2), 1-12, 2023 | 5 | 2023 |
Biological and therapeutic implications of the cancer-related germline mutation landscape in lung cancer E Panagiotou, IA Vathiotis, P Makrythanasis, F Hirsch, T Sen, K Syrigos The Lancet Respiratory Medicine, 2024 | 3 | 2024 |
Unravelling the diagnostic pathology and molecular biomarkers in lung cancer A Charpidou, G Hardavella, E Boutsikou, E Panagiotou, GÖ Simsek, ... Breathe 20 (2), 2024 | 3 | 2024 |
A Machine Learning-Based Web Tool for the Severity Prediction of COVID-19 A Christodoulou, MS Katsarou, C Emmanouil, M Gavrielatos, D Georgiou, ... BioTech 13 (3), 22, 2024 | 2 | 2024 |
High-dose bevacizumab for radiation-induced brain necrosis: a case report E Panagiotou, A Charpidou, E Fyta, V Nikolaidou, L Stournara, A Syrigos, ... CNS oncology 12 (3), CNS98, 2023 | 2 | 2023 |
Endocrine Immune-Related Adverse Events Are Independent Predictors of Survival in Patients with Lung Cancer E Panagiotou, S Ntouraki, IA Vathiotis, ME Livanou, A Trimis, ... Cancers 16 (9), 1764, 2024 | 1 | 2024 |
Pulmonary benign metastasizing leiomyoma: a case report E Panagiotou, I Vamvakaris, NK Syrigos, E Kotteas Monaldi Archives for Chest Disease 94 (1), 2024 | 1 | 2024 |
Eligibility for screening with low-dose CT in a real-world cohort of patients with lung cancer in Greece: A brief report ME Livanou, NK Syrigos, A Montgomery, C Moeckel, E Panagiotou, ... Lung Cancer 186, 107424, 2023 | 1 | 2023 |
Real-world survival outcomes to first-line chemoimmunotherapy and biomarker analysis in extensive-stage small-cell lung cancer E Panagiotou, IA Vathiotis, A Montgomery, C Moeckel, ME Livanou, ... | 1* | 2023 |
Lung cancer and inequalities in access to multidisciplinary lung cancer services G Hardavella, A Charpidou, A Frille, E Panagiotou, MJ Catarata, ... Inequalities in Respiratory Health, 153, 2023 | 1 | 2023 |
Prolonged SARS-CoV-2 Infection With Common Features in Two Patients Receiving Anti-CD20 Therapy A Papanikolopoulou, V Thimis, E Antonogiannaki, V Rapti, K Tsiakos, ... in vivo 37 (1), 461-467, 2023 | 1 | 2023 |
Molecular interactions of antibodies with PD-1/PD-L1 proteins S Vasilakaki, I Vathiotis, E Panagiotou, E Dimakakos, G Gomatou, ... Immunotherapy 16 (1), 21-28, 2024 | | 2024 |
EP06. 03-07 Clinical Impact of Next-Generation Sequencing in KRAS-Mutated Non-Small Cell Lung Cancer Patients: a Single-Center Experience M Anagnostakis, E Panagiotou, A Karachaliou, V Kolintzikis, I Tsamis, ... Journal of Thoracic Oncology 18 (11), S485, 2023 | | 2023 |
Pulmonary metastasis of solid tumours E Zervas, K Samitas, I Vlachantoni, S Karakatsanis, E Panagiotou, ... Lung Diseases and Cancer 98, 212, 2022 | | 2022 |
Pulmonary metastasis: from pathophysiology to management A Charpidou, E Panagiotou, S Karakatsanis, K Samitas, K Tavernaraki, ... Lung Diseases and Cancer 98, 190, 2022 | | 2022 |